Michael S. Sinha

Michael S. Sinha is an Assistant Professor at the Center for Health Law Studies, School of Law, Saint Louis University. He holds an M.D., J.D., and M.P.H., with expertise at the intersection of medicine and law. His research focuses on pharmaceutical policy, intellectual property, and gender equity in healthcare. Previously, he served at Harvard Medical School, Northeastern University School of Law, and Loyola University Chicago School of Law. Dr. Sinha is affiliated with the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women’s Hospital and the Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) at the University of Copenhagen.

Education:

• M.P.H., Harvard T.H. Chan School of Public Health (2015)
• J.D., SIU School of Law (2012)
• M.D., SIU School of Medicine (2012)
• B.A., Dartmouth College (2003)

Research Interests: Pharmaceutical competition, intellectual property law, gender equity in medicine, and public health policy.

Professional Affiliations: Fellow of the American College of Legal Medicine, member of the American Medical Association, and founder of the American Medical Women’s Association’s Action Coalition for Equity.

Publications: Over 50 peer-reviewed articles in journals like JAMA, Health Affairs, and Food and Drug Law Journal, focusing on health law, regulatory science, and biomedical innovation. Recent work addresses FDA policy, opioid crisis accountability, and AI in healthcare.

Labs/Teams: Collaborates with PORTAL and CeBIL on projects related to drug regulation and biomedical innovation law.